G. Nuyts

1.1k total citations
23 papers, 753 citations indexed

About

G. Nuyts is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Nuyts has authored 23 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in G. Nuyts's work include Gastrointestinal motility and disorders (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Alkaline Phosphatase Research Studies (3 papers). G. Nuyts is often cited by papers focused on Gastrointestinal motility and disorders (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Alkaline Phosphatase Research Studies (3 papers). G. Nuyts collaborates with scholars based in Belgium, United States and Australia. G. Nuyts's co-authors include Nicholas J. Talley, Dominique Dubois, Michael Jones, Marc E. De Broe, Monique Elseviers, Patrick C. D’Haese, R. Daelemans, R. Lins, E. Van Vlem and J.P. Thys and has published in prestigious journals such as The Lancet, Gastroenterology and Clinical Chemistry.

In The Last Decade

G. Nuyts

23 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Nuyts Belgium 13 240 200 143 130 121 23 753
Mirela Dobre United States 21 43 0.2× 156 0.8× 252 1.8× 849 6.5× 53 0.4× 55 1.5k
António W. Gomes‐Neto Netherlands 18 30 0.1× 158 0.8× 108 0.8× 191 1.5× 21 0.2× 68 923
Chi‐Jung Chung Taiwan 14 22 0.1× 127 0.6× 97 0.7× 76 0.6× 30 0.2× 32 500
Maria Eugênia Fernandes Canziani Brazil 19 44 0.2× 146 0.7× 136 1.0× 618 4.8× 15 0.1× 59 1.0k
Youbao Li China 19 27 0.1× 138 0.7× 124 0.9× 242 1.9× 30 0.2× 56 1.1k
I M Stewart United Kingdom 16 57 0.2× 210 1.1× 64 0.4× 17 0.1× 17 0.1× 32 786
Nathalie Léone France 11 29 0.1× 81 0.4× 435 3.0× 23 0.2× 119 1.0× 11 918
Apurv Khanna United States 12 25 0.1× 45 0.2× 147 1.0× 392 3.0× 35 0.3× 24 716
Elena Kamycheva Norway 16 39 0.2× 91 0.5× 48 0.3× 184 1.4× 30 0.2× 25 1.1k
Z Szybiński Poland 17 19 0.1× 167 0.8× 55 0.4× 103 0.8× 40 0.3× 91 918

Countries citing papers authored by G. Nuyts

Since Specialization
Citations

This map shows the geographic impact of G. Nuyts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Nuyts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Nuyts more than expected).

Fields of papers citing papers by G. Nuyts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Nuyts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Nuyts. The network helps show where G. Nuyts may publish in the future.

Co-authorship network of co-authors of G. Nuyts

This figure shows the co-authorship network connecting the top 25 collaborators of G. Nuyts. A scholar is included among the top collaborators of G. Nuyts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Nuyts. G. Nuyts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuyts, G., Sigrid K. McAllister, Andrew J. Muir, et al.. (2011). PGI23 WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAÏVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES. Value in Health. 14(3). A184–A184. 1 indexed citations
2.
Muir, Andrew J., Sandra Gavart, G. Nuyts, et al.. (2011). Impact of Telaprevir-Based Treatment Regimens on Fatigue in Genotype 1 HCV Treatment-NaïVE Patients: Results From Advance and Illuminate Studies. Gastroenterology. 140(5). S–944. 1 indexed citations
3.
Nuyts, G., Kate Hill, & Michael Jones. (2008). Current practice and resource utilisation in men diagnosed with premature ejaculation. International Journal of Clinical Practice. 62(10). 1533–1540. 1 indexed citations
4.
Talley, Nicholas J., Michael Jones, G. Nuyts, & Dominique Dubois. (2003). Risk Factors for Chronic Constipation Based on A General Practice Sample. The American Journal of Gastroenterology. 98(5). 1107–1111. 173 indexed citations
5.
Radbruch, Lukas, et al.. (2002). Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine. The European Journal of Health Economics. 3(2). 111–119. 16 indexed citations
6.
Jones, Michael, Nicholas J. Talley, G. Nuyts, & Dominique Dubois. (2002). Lack of Objective Evidence of Efficacy of Laxatives in Chronic Constipation. Digestive Diseases and Sciences. 47(10). 2222–2230. 98 indexed citations
7.
Lecomte, Pascal, et al.. (2000). A 1-Year Cost-Effectiveness Model for the Treatment of Chronic Schizophrenia with Acute Exacerbations in Belgium. Value in Health. 3(1). 1–11. 25 indexed citations
8.
Frei, Andreas, et al.. (2000). NR3: ECONOMIC EVALUATION OF TRANSDERMAL FENTANYL IN THE TREATMENT OF CHRONIC NON-CANCER PAIN IN DENMARK. Value in Health. 3(5). 309–309. 2 indexed citations
9.
Nuyts, G., Dominique Dubois, Michael Jones, & Nicholas J. Talley. (2000). Risk factors for chronic constipation: A case-control study in a large general practice population. Gastroenterology. 118(4). A693–A693. 1 indexed citations
10.
Binder, Marc D., Marc Van Dijk, Pascal Lecomte, & G. Nuyts. (2000). A one year cost-effectiveness model for the treatment of chronic schizophrenia in Belgium. European Neuropsychopharmacology. 10. 316–316. 2 indexed citations
11.
Gregorini, Gina, Paola Tira, Patrick C. D’Haese, et al.. (1997). ANCA-associated diseases and silica exposure. Clinical Reviews in Allergy & Immunology. 15(1). 21–40. 41 indexed citations
12.
Broe, Marc E. De, et al.. (1996). Occupational renal diseases. Current Opinion in Nephrology & Hypertension. 5(2). 114–121. 8 indexed citations
13.
Nuyts, G., Patrick C. D’Haese, Monique Elseviers, et al.. (1995). New occupational risk factors for chronic renal failure. The Lancet. 346(8966). 7–11. 72 indexed citations
14.
Nuyts, G., E. Van Vlem, R. Daelemans, et al.. (1995). Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrology Dialysis Transplantation. 10(7). 1162–1165. 62 indexed citations
15.
Lins, R., et al.. (1993). Urinary enzymes in acute renal failure. Nephrology Dialysis Transplantation. 8(6). 507–511. 82 indexed citations
16.
Nuyts, G., et al.. (1992). Intestinal-type alkaline phosphatase in urine as an indicator of mercury induced effects on the S3 segment of the proximal tubule. Nephrology Dialysis Transplantation. 7(3). 225–229. 11 indexed citations
17.
Mutti, Antonio, Rossella Alinovi, Enrico Bergamaschi, et al.. (1992). Nephropathies and exposure to perchloroethylene in dry-cleaners. The Lancet. 340(8813). 189–193. 72 indexed citations
18.
Nuyts, G., et al.. (1992). Immunoassay in Urine of a Specific Marker for Proximal Tubular S3 Segment. Clinical Chemistry. 38(5). 642–647. 19 indexed citations
19.
Nuyts, G., et al.. (1991). Does Lead Play a Role in the Development of Chronic Renal Disease?. Nephrology Dialysis Transplantation. 6(5). 307–315. 16 indexed citations
20.
Nuyts, G., Monique Elseviers, & Marc E. De Broe. (1989). Health impact of renal disease due to nephrotoxicity. Toxicology Letters. 46(1-3). 31–44. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirela Dobre Breakdown of academic impact, for papers by António W. Gomes‐Neto Breakdown of academic impact, for papers by Chi‐Jung Chung Breakdown of academic impact, for papers by Maria Eugênia Fernandes Canziani Breakdown of academic impact, for papers by Youbao Li Breakdown of academic impact, for papers by I M Stewart Breakdown of academic impact, for papers by Nathalie Léone Breakdown of academic impact, for papers by Apurv Khanna Breakdown of academic impact, for papers by Elena Kamycheva Breakdown of academic impact, for papers by Z Szybiński
Rankless by CCL
2026